当前位置:首页 - 行情中心 - 九典制药(300705) - 财务分析 - 现金流量表

九典制药

(300705)

  

流通市值:60.57亿  总市值:81.93亿
流通股本:3.70亿   总股本:5.00亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,556,738,110.521,674,686,634.09811,316,501.783,460,354,224.96
  收到的税费返还2,592,948.562,592,948.561,666,740.522,256,973.04
  收到其他与经营活动有关的现金78,084,760.9362,325,697.4861,472,796.14123,256,592.49
  经营活动现金流入小计2,637,415,820.011,739,605,280.13874,456,038.443,585,867,790.49
  购买商品、接受劳务支付的现金543,555,009.04359,739,591.74200,618,577.34794,324,036.37
  支付给职工以及为职工支付的现金300,573,601.96208,844,810.54123,543,820.88348,595,207.82
  支付的各项税费227,211,659.54160,612,709.6774,193,342.02307,275,725.56
  支付其他与经营活动有关的现金1,110,306,616.31734,515,304.29328,796,446.051,389,308,235.89
  经营活动现金流出小计2,181,646,886.851,463,712,416.24727,152,186.292,839,503,205.64
  经营活动产生的现金流量净额455,768,933.16275,892,863.89147,303,852.15746,364,584.85
二、投资活动产生的现金流量:
  收回投资收到的现金570,000,000455,000,000200,000,000531,000,000
  取得投资收益收到的现金2,567,260.32,114,567.381,248,878.083,273,510.6
  处置固定资产、无形资产和其他长期资产收回的现金净额418,984.6332,761.41603115,849.13
  投资活动现金流入小计572,986,244.9457,447,328.79201,249,481.08534,389,359.73
  购建固定资产、无形资产和其他长期资产支付的现金343,931,639.48146,985,660.4166,155,019.31397,867,747.63
  投资支付的现金515,199,000386,999,000180,000,000788,124,000
  取得子公司及其他营业单位支付的现金8,342,612.140--
  支付其他与投资活动有关的现金-0--
  投资活动现金流出小计867,473,251.62533,984,660.41246,155,019.311,185,991,747.63
  投资活动产生的现金流量净额-294,487,006.72-76,537,331.62-44,905,538.23-651,602,387.9
三、筹资活动产生的现金流量:
  吸收投资收到的现金26,652,629.8325,152,629.83019,170,137.12
  其中:子公司吸收少数股东投资收到的现金1,500,000000
  取得借款收到的现金184,075,680139,175,68056,775,68081,400,000
  筹资活动现金流入小计210,728,309.83164,328,309.8356,775,680100,570,137.12
  偿还债务支付的现金4,666,7004,000,000061,200,371.16
  分配股利、利润或偿付利息支付的现金158,940,313.92156,172,568.39968,836.07115,711,143.26
  支付其他与筹资活动有关的现金100,047,173.88100,001,068.884,995,170.26112,242.38
  筹资活动现金流出小计263,654,187.8260,173,637.275,964,006.33177,023,756.8
  筹资活动产生的现金流量净额-52,925,877.97-95,845,327.4450,811,673.67-76,453,619.68
四、汇率变动对现金及现金等价物的影响-21,623.22-11,601.3700
五、现金及现金等价物净增加额108,334,425.25103,498,603.46153,209,987.5918,308,577.27
  加:期初现金及现金等价物余额433,519,353.39433,519,353.39433,519,353.39415,210,776.12
  期末现金及现金等价物余额541,853,778.64537,017,956.85586,729,340.98433,519,353.39
补充资料:
  净利润-291,423,208.95-512,377,174.16
  资产减值准备-3,958,590.08-3,024,507.13
  固定资产和投资性房地产折旧-52,329,915.63-88,883,462.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-52,329,915.63-88,883,462.15
  无形资产摊销-4,221,861.51-5,982,359.68
  长期待摊费用摊销-859,710.53-1,663,406.9
  固定资产报废损失-1,028,593.65-1,916,400.78
  财务费用-6,875,975.94-18,856,419.11
  投资损失--226,199.83--3,111,376.25
  递延所得税-5,614,434.48-17,131,258.88
  其中:递延所得税资产减少-5,868,167.33-16,779,705.05
    递延所得税负债增加--253,732.85-351,553.83
  存货的减少--40,014,009.43--91,250,933.1
  经营性应收项目的减少--35,572,019.62-137,011,267.25
  经营性应付项目的增加--14,870,836.21-48,912,878.81
  其他-212,116.01-4,864,714.99
  现金的期末余额-537,017,956.85-433,519,353.39
  减:现金的期初余额-433,519,353.39-415,210,776.12
  现金及现金等价物的净增加额-103,498,603.46-18,308,577.27
公告日期2025-10-302025-08-232025-04-242025-04-24
审计意见(境内)标准无保留意见
TOP↑